Crohn's disease exacerbated by IL-17 inhibitors in patients with psoriasis: a case report.
BACKGROUND
Previous studied revealed that psoriasis and Inflammatory bowel disease (IBD) have highly overlapping epidemiological characteristics, genetic susceptibility loci, disease risk factors, immune mechanisms, and comorbidities. More and more biologics have been used to treat psoriasis and IBD. Interleukin (IL)-17 inhibitors played an important role in the treatment of psoriasis, but induced and aggravated inflammatory bowel disease in some patients. IL-23 inhibitors have shown to be effective to both psoriasis and CD.


CASE PRESENTATION
Forty-one year old Chinese male patient who came to the hospital for psoriasis, developed severe gastrointestinal symptoms after using an IL-17 inhibitor, and was diagnosed with Crohn's disease (CD). The patient eventually used an IL-23 inhibitor to relieve both psoriasis and CD.


CONCLUSION
IBD patients and psoriasis patients have increased probability of suffering from the other disease. The case that patients had suffered from psoriasis and CD before the use of IL-17 inhibitor is quite rare. This case suggests that physicians need to be careful when treating patients with psoriasis and CD with biologics, and it is necessary to evaluate the gastrointestinal tract.
['Ju|Jingyi|J|', 'Dai|Yuanyuan|Y|', 'Yang|Jiaolan|J|', 'Liu|Changqin|C|', 'Fan|Li|L|', 'Feng|Lijin|L|', 'Zhao|Binghui|B|', 'Zeng|Meiying|M|', 'Liu|Zhanju|Z|', 'Sun|Xiaomin|X|http://orcid.org/0000-0001-9307-4735']
D000328:Adult D003424:Crohn Disease D006801:Humans D020381:Interleukin-17 D008297:Male D011565:Psoriasis
IL-17 inhibitor Psoriasis Inflammatory bowel disease IL-23 inhibitor Crohn’s disease